Loading clinical trials...
Loading clinical trials...
A Multi-Center, Prospective, Parallel Group, Randomized, Pilot Study Evaluating Safety And Preliminary Effectiveness Of NB1 Bone Graft In Subjects With Degenerative Disc Disease Undergoing Transforaminal Lumbar Interbody Fusion
The objective of this clinical study is to evaluate the safety and effectiveness of NB1 Bone Graft in subjects with degenerative disc disease undergoing transforaminal lumbar interbody fusion. It is estimated that up to 30 participants will be enrolled in approximately 3 clinical sites. During baseline and follow-up assessments, patients will be asked to undergo x-rays and CT scans; adverse events and immunology will be collected, and; participants will be requested to complete participant questionnaires regarding quality of life, pain and function.
Age
17 - 70 years
Sex
ALL
Healthy Volunteers
No
Monash Medical Center
Clayton, Victoria, Australia
St Vincent Melbourne
Fitzroy, Australia
St George Hospital
Kogarah, Australia
Start Date
March 1, 2024
Primary Completion Date
June 1, 2025
Completion Date
June 1, 2026
Last Updated
March 12, 2024
30
ESTIMATED participants
NB1
DEVICE
Lead Sponsor
Bone Biologics Corp
NCT07254806
NCT05508360
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT05037968